Nexgel (NXGL) EPS (Weighted Average and Diluted) (2018 - 2025)
Nexgel (NXGL) has disclosed EPS (Weighted Average and Diluted) for 8 consecutive years, with -$0.08 as the latest value for Q3 2025.
- For the quarter ending Q3 2025, EPS (Weighted Average and Diluted) rose 24.18% year-over-year to -$0.08, compared with a TTM value of -$0.08 through Sep 2025, up 85.86%, and an annual FY2024 reading of -$0.53, up 5.03% over the prior year.
- EPS (Weighted Average and Diluted) was -$0.08 for Q3 2025 at Nexgel, roughly flat from -$0.08 in the prior quarter.
- Across five years, EPS (Weighted Average and Diluted) topped out at -$0.08 in Q3 2025 and bottomed at -$1.42 in Q4 2021.
- Average EPS (Weighted Average and Diluted) over 5 years is -$0.24, with a median of -$0.14 recorded in 2024.
- The sharpest move saw EPS (Weighted Average and Diluted) plummeted 3700.0% in 2021, then skyrocketed 91.81% in 2022.
- Year by year, EPS (Weighted Average and Diluted) stood at -$1.42 in 2021, then soared by 91.81% to -$0.12 in 2022, then plummeted by 72.06% to -$0.2 in 2023, then skyrocketed by 36.65% to -$0.13 in 2024, then skyrocketed by 34.17% to -$0.08 in 2025.
- Business Quant data shows EPS (Weighted Average and Diluted) for NXGL at -$0.08 in Q3 2025, -$0.08 in Q2 2025, and -$0.09 in Q1 2025.